Mylan voluntarily discontinued Creon 40K in June 2019. It is important to note that, Creon Micro, Creon 10K and Creon 25K has continued, and will continue, to be manufactured.
Creon capsules are interchangeable, and patients can achieve the higher dose by taking more of the lower strength capsules. Patients should not be concerned about the efficacy when switching to a lower strength capsule.
Information for Patients and Prescribers
Mylan is unable to make any specific treatment recommendations to healthcare professionals or for individual patients, however, it is recommended that patients speak to their treating physician to discuss treatment options according to their health needs and their relevant clinical history.
About Creon
Creon is a Pancreatic Enzyme Replacement Therapy (PERT) that helps patients with Pancreatic Exocrine Insufficiency (PEI) to break down food and digest nutrients by replacing the pancreatic enzymes made by a healthy pancreas. The active substance of Creon is pancreatin, a natural substance from the pancreas of the pig; as a biologic product Creon is produced using a complex manufacturing process that is subject to high standards and strict requirements in terms of quality and compliance.
Contact Information
If you require additional information or have any questions, please contact our medical
information team on 01707 853 000 or via email: info.uk@mylan.co.uk
Adverse events should be reported. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. You should also inform the company who markets Creon in the UK directly via ukpharmacovigilance@mylan.com or +44 (0)800 121 8267.
CRE-2020-0229
DOP: March 2020
Please select from below depending on whether you are
a Creon patient, or a UK Healthcare Professional
This website uses cookies. By continuing to use this website, you consent to our use of these cookies. You can find out more about how we use cookies and how to manage them by reading our Cookie Policy
You will now leave the Creon patient website and go to the Creon Track site where you can join the Creon Track patient support programme
Would you like to proceed to the Creon Track registration website?
